Find Galantamine Benzoate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Gln-1062, 224169-27-1, Galantamine benzoate, Xoi2q0zf7g, 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, benzoate (ester), (4as,6r,8as)-, Benzgalantamine
Molecular Formula
C24H25NO4
Molecular Weight
391.5  g/mol
InChI Key
JKVNJTYHRABHIY-WXVUKLJWSA-N
FDA UNII
XOI2Q0ZF7G

Galantamine Benzoate
1 2D Structure

Galantamine Benzoate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-yl] benzoate
2.1.2 InChI
InChI=1S/C24H25NO4/c1-25-13-12-24-11-10-18(28-23(26)16-6-4-3-5-7-16)14-20(24)29-22-19(27-2)9-8-17(15-25)21(22)24/h3-11,18,20H,12-15H2,1-2H3/t18-,20-,24-/m0/s1
2.1.3 InChI Key
JKVNJTYHRABHIY-WXVUKLJWSA-N
2.1.4 Canonical SMILES
CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)OC(=O)C5=CC=CC=C5
2.1.5 Isomeric SMILES
CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)OC(=O)C5=CC=CC=C5
2.2 Other Identifiers
2.2.1 UNII
XOI2Q0ZF7G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gln-1062

2.3.2 Depositor-Supplied Synonyms

1. Gln-1062

2. 224169-27-1

3. Galantamine Benzoate

4. Xoi2q0zf7g

5. 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, Benzoate (ester), (4as,6r,8as)-

6. Benzgalantamine

7. Unii-xoi2q0zf7g

8. Benzgalantamine [inn]

9. Schembl16885442

10. [(1s,12s,14r)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-yl] Benzoate

11. Gln 1062

12. Cs-6749

13. Hy-101710

2.4 Create Date
2009-10-26
3 Chemical and Physical Properties
Molecular Weight 391.5 g/mol
Molecular Formula C24H25NO4
XLogP34.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass391.17835828 g/mol
Monoisotopic Mass391.17835828 g/mol
Topological Polar Surface Area48 Ų
Heavy Atom Count29
Formal Charge0
Complexity645
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

GLP Bio

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Digital Meet
Not Confirmed
arrow

GLP Bio

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Biotech Digital Meet
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

02

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Digital Meet
Not Confirmed
arrow

FandaChem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Biotech Digital Meet
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

Axon Medchem

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Digital Meet
Not Confirmed
arrow

Axon Medchem

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Biotech Digital Meet
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Haoyuan Chemexpress Co.Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Biotech Digital Meet
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Under the licensing agreement, CMS will hold the exclusive right for the development, manufacturing, and commercialization of Zunveyl (benzgalantamine) for the treatment of Alzheimer’s disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: Zunveyl

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: China Medical System Holdings Limited

Deal Size: $44.0 million Upfront Cash: $6.0 million

Deal Type: Licensing Agreement January 08, 2025

blank

01

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Lead Product(s) : Galantamine Benzoate

Therapeutic Area : Neurology

Highest Development Status : Approved FDF

Partner/Sponsor/Collaborator : China Medical System Holdings Limited

Deal Size : $44.0 million

Deal Type : Licensing Agreement

Details : Under the licensing agreement, CMS will hold the exclusive right for the development, manufacturing, and commercialization of Zunveyl (benzgalantamine) for the treatment of Alzheimer’s disease.

Product Name : Zunveyl

Product Type : Other Small Molecule

Upfront Cash : $6.0 million

January 08, 2025

blank

Details:

Zunveyl (benzgalantamine) is a new generation acetylcholinesterase inhibitor. It is being evaluated for treatment of repetitive mild traumatic brain injury.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Undisclosed

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 11, 2024

blank

02

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : Zunveyl (benzgalantamine) is a new generation acetylcholinesterase inhibitor. It is being evaluated for treatment of repetitive mild traumatic brain injury.

Product Name : Undisclosed

Product Type : Small molecule

Upfront Cash : Not Applicable

December 11, 2024

blank

Details:

The Company intends to use the proceeds towards the commercialization and launch of Zunveyl (benzgalantamine) for the treatment of mild-to-moderate Alzheimer’s Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: Zunveyl

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Titan Partners Group

Deal Size: $50.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering November 12, 2024

blank

03

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The Company intends to use the proceeds towards the commercialization and launch of Zunveyl (benzgalantamine) for the treatment of mild-to-moderate Alzheimer’s Disease.

Product Name : Zunveyl

Product Type : Small molecule

Upfront Cash : Undisclosed

November 12, 2024

blank

Details:

The proceeds from the financing will be utilized to continue commercialization work for the Company’s recently approved Zunveyl (benzgalantamine), indicated for the treatment of Alzheimer's disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: Zunveyl

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: The Benchmark Company, LLC

Deal Size: $4.5 million Upfront Cash: Undisclosed

Deal Type: Financing September 24, 2024

blank

04

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The proceeds from the financing will be utilized to continue commercialization work for the Company’s recently approved Zunveyl (benzgalantamine), indicated for the treatment of Alzheimer's disease.

Product Name : Zunveyl

Product Type : Small molecule

Upfront Cash : Undisclosed

September 24, 2024

blank

Details:

ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: Zunveyl

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 29, 2024

blank

05

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine.

Product Name : Zunveyl

Product Type : Small molecule

Upfront Cash : Not Applicable

July 29, 2024

blank

Details:

The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: ALPHA-1062

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $6.5 million Upfront Cash: Undisclosed

Deal Type: Public Offering December 22, 2023

blank

06

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.

Product Name : ALPHA-1062

Product Type : Small molecule

Upfront Cash : Undisclosed

December 22, 2023

blank

Details:

ALPHA-1062 (benzgalantamine), AChE inhibitor delayed-release oral tablet formulation. Currently being evaluated in the Phase III clinical trial studies for the treatment of mild-to-moderate Alzheimer’s Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: ALPHA-1062

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 07, 2023

blank

07

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : ALPHA-1062 (benzgalantamine), AChE inhibitor delayed-release oral tablet formulation. Currently being evaluated in the Phase III clinical trial studies for the treatment of mild-to-moderate Alzheimer’s Disease.

Product Name : ALPHA-1062

Product Type : Small molecule

Upfront Cash : Not Applicable

December 07, 2023

blank

Details:

The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: ALPHA-1062

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $6.5 million Upfront Cash: Undisclosed

Deal Type: Private Placement December 04, 2023

blank

08

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.

Product Name : ALPHA-1062

Product Type : Small molecule

Upfront Cash : Undisclosed

December 04, 2023

blank

Details:

The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: ALPHA-1062

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Spartan Capital Securities

Deal Size: $6.5 million Upfront Cash: Undisclosed

Deal Type: Private Placement November 08, 2023

blank

09

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.

Product Name : ALPHA-1062

Product Type : Small molecule

Upfront Cash : Undisclosed

November 08, 2023

blank

Details:

The Company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.


Lead Product(s): Galantamine Benzoate

Therapeutic Area: Neurology Brand Name: ALPHA-1062

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $97.8 million Upfront Cash: Undisclosed

Deal Type: Private Placement October 16, 2023

blank

10

Biotech Digital Meet
Not Confirmed
Biotech Digital Meet
Not Confirmed

Details : The Company expects to use the net proceeds for research and development of ALPHA-1062 (benzgalantamine), a prodrug of an approved acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer's Disease.

Product Name : ALPHA-1062

Product Type : Small molecule

Upfront Cash : Undisclosed

October 16, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Galantamine Benzoate

Brand Name : Zunveyl

Dosage Form :

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for 224169-27-1 / Galantamine Benzoate API manufacturers, exporters & distributors?

Galantamine Benzoate manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Galantamine Benzoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Galantamine Benzoate manufacturer or Galantamine Benzoate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Galantamine Benzoate manufacturer or Galantamine Benzoate supplier.

PharmaCompass also assists you with knowing the Galantamine Benzoate API Price utilized in the formulation of products. Galantamine Benzoate API Price is not always fixed or binding as the Galantamine Benzoate Price is obtained through a variety of data sources. The Galantamine Benzoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Galantamine Benzoate

Synonyms

Gln-1062, 224169-27-1, Xoi2q0zf7g, 6h-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, benzoate (ester), (4as,6r,8as)-, Benzgalantamine, Unii-xoi2q0zf7g

Cas Number

224169-27-1

Unique Ingredient Identifier (UNII)

XOI2Q0ZF7G

Galantamine Benzoate Manufacturers

A Galantamine Benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galantamine Benzoate, including repackagers and relabelers. The FDA regulates Galantamine Benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galantamine Benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Galantamine Benzoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Galantamine Benzoate Suppliers

A Galantamine Benzoate supplier is an individual or a company that provides Galantamine Benzoate active pharmaceutical ingredient (API) or Galantamine Benzoate finished formulations upon request. The Galantamine Benzoate suppliers may include Galantamine Benzoate API manufacturers, exporters, distributors and traders.

click here to find a list of Galantamine Benzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Galantamine Benzoate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Galantamine Benzoate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Galantamine Benzoate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Galantamine Benzoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Galantamine Benzoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Galantamine Benzoate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Galantamine Benzoate suppliers with NDC on PharmaCompass.

Galantamine Benzoate GMP

Galantamine Benzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Galantamine Benzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Galantamine Benzoate GMP manufacturer or Galantamine Benzoate GMP API supplier for your needs.

Galantamine Benzoate CoA

A Galantamine Benzoate CoA (Certificate of Analysis) is a formal document that attests to Galantamine Benzoate's compliance with Galantamine Benzoate specifications and serves as a tool for batch-level quality control.

Galantamine Benzoate CoA mostly includes findings from lab analyses of a specific batch. For each Galantamine Benzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Galantamine Benzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Galantamine Benzoate EP), Galantamine Benzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galantamine Benzoate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty